Staidson BioPharm(SZ:300204) Xin Lang Cai Jing·2025-08-29 03:07Core Viewpoint - The stock of Shuyou Shen has experienced significant fluctuations, with a year-to-date increase of 587.45%, but a recent decline in the last five and twenty trading days [1][2]. Group 1: Stock Performance - As of August 29, Shuyou Shen's stock price was 50.94 CNY per share, with a market capitalization of 24.338 billion CNY [1]. - The stock has seen a trading volume of 3.21 billion CNY, with a turnover rate of 1.36% [1]. - Year-to-date, the stock has risen by 587.45%, but has decreased by 2.99% in the last five trading days and 2.17% in the last twenty trading days [1]. Group 2: Financial Performance - For the first half of 2025, Shuyou Shen reported a revenue of 126 million CNY, a year-on-year decrease of 31.14% [2]. - The net profit attributable to shareholders was -24.636 million CNY, representing a year-on-year decrease of 619.70% [2]. Group 3: Shareholder Information - As of June 30, 2025, the number of shareholders increased by 29.20% to 31,700 [2]. - The average number of circulating shares per shareholder decreased by 22.60% to 14,327 shares [2]. - The company has cumulatively distributed 771 million CNY in dividends since its A-share listing, with no dividends distributed in the last three years [3]. Group 4: Institutional Holdings - As of June 30, 2025, several new institutional shareholders have emerged among the top ten circulating shareholders, including: - Xingquan Helun Mixed A (163406) as the third-largest shareholder with 15.721 million shares [3]. - Xingquan Commercial Model Mixed (LOF) A (163415) as the fifth-largest shareholder with 8.805 million shares [3]. - Other new shareholders include Xingquan New Vision and Yongying Medical Innovation [3].